Mapping the Spatial Distribution of Fibrillar Polymorphs in Human Brain Tissue
- Northeastern University, Boston, MA (United States)
- Massachusetts Alzheimer’s Disease Research Center, Boston, MA (United States)
- Massachusetts Alzheimer’s Disease Research Center, Boston, MA (United States); Massachusetts General Hospital, Boston, MA (United States); Harvard Medical School, Boston, MA (United States)
- Massachusetts Alzheimer’s Disease Research Center, Boston, MA (United States); Massachusetts General Hospital, Boston, MA (United States)
- Brookhaven National Laboratory (BNL), Upton, NY (United States)
Alzheimer’s disease (AD) is a neurodegenerative disorder defined by the progressive formation and spread of fibrillar aggregates of Aβ peptide and tau protein. Polymorphic forms of these aggregates may contribute to disease in varying ways since different neuropathologies appear to be associated with different sets of fibrillar structures and follow distinct pathological trajectories that elicit characteristic clinical phenotypes. The molecular mechanisms underlying the spread of these aggregates in disease may include nucleation, replication, and migration all of which could vary with polymorphic form, stage of disease, and region of brain. Given the linkage between mechanisms of progression and distribution of polymorphs, mapping the distribution of fibrillar structures in situ has the potential to discriminate between mechanisms of progression. However, the means of carrying out this mapping are limited. Optical microscopy lacks the resolution to discriminate between polymorphs in situ, and higher resolution tools such as ssNMR and cryoEM require the isolation of fibrils from tissue, destroying relevant spatial information. Here, we demonstrate the use of scanning x-ray microdiffraction (XMD) to map the locations of fibrillar polymorphs of Aβ peptides and tau protein in histological thin sections of human brain tissue. Coordinated examination of serial sections by immunohistochemistry was used to aid in the interpretation of scattering patterns and to put the observations in a broader anatomical context. Scattering from lesions in tissue shown to be rich in Aβ fibrils by immunohistochemistry exhibited scattering patterns with a prototypical 4.7 Å cross-β peak, and overall intensity distribution that compared well with that predicted from high resolution structures. Scattering from lesions in tissue with extensive tau pathology also exhibited a 4.7 Å cross-β peak but with intensity distributions that were distinct from those seen in Aβ-rich regions. In summary, these observations demonstrate that XMD is a rich source of information on the distribution of fibrillar polymorphs in diseased human brain tissue. When used in coordination with neuropathological examination it has the potential to provide novel insights into the molecular mechanisms underlying disease.
- Research Organization:
- Brookhaven National Laboratory (BNL), Upton, NY (United States). National Synchrotron Light Source II (NSLS-II)
- Sponsoring Organization:
- USDOE Office of Science (SC), Basic Energy Sciences (BES). Scientific User Facilities (SUF); USDOE Office of Science (SC), Biological and Environmental Research (BER); National Institutes of Health (NIH); Alzheimer’s Association Clinician Scientist Fellowship; National Institute on Aging
- Grant/Contract Number:
- SC0012704
- OSTI ID:
- 2470331
- Journal Information:
- Frontiers in Neuroscience (Online), Journal Name: Frontiers in Neuroscience (Online) Vol. 16; ISSN 1662-453X
- Publisher:
- Frontiers Research FoundationCopyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
De novo designed protein inhibitors of amyloid aggregation and seeding
Amyloid structure exhibits polymorphism on multiple length scales in human brain tissue